广州安必平医药科技股份有限公司2024年年度股东大会决议公告

Group 1 - The board of directors guarantees that the announcement contains no false records, misleading statements, or significant omissions, and assumes legal responsibility for its authenticity, accuracy, and completeness [1] - The shareholder meeting was held at the company's conference room located at No. 2, Kexin Street, Huangpu District, Guangzhou [2] - The voting method for the meeting was conducted both on-site and online, complying with the Company Law and the company's articles of association [3] Group 2 - The meeting was convened by the board of directors and chaired by Mr. Cai Xiangting, the chairman [5] - All 9 current directors and 3 current supervisors attended the meeting, along with the board secretary and other senior executives [5] - The meeting approved several proposals, including the 2024 annual report and its summary, the 2024 board work report, and the 2024 profit distribution plan [6][6][6] Group 3 - The meeting also approved the reappointment of the accounting firm and the financial settlement report for 2024 [6][6] - A proposal for the board to issue shares to specific targets through a simplified procedure was also approved [6] - The legal proceedings of the shareholder meeting were confirmed to comply with the Company Law and relevant regulations, ensuring the legality and validity of the meeting's proceedings and results [7]